Table 3 Clinical characteristics of patients carrying the APOA5 mutation and others

Age (years)

39.96 ± 8.40

39.98 ± 9.18

39.43 ± 11.54

0.992

0.782

0.784

Male, n (%)

41, 79%

39, 78%

52, 85%

0.917

0.374

0.323

Hospital stay (days)

9.65 ± 5.52

11.58 ± 10.23

10.26 ± 5.62

0.24

0.274

0.796

BMI (kg/m²)

27.44 ± 3.65

27.72 ± 3.17

27.60 ± 4.05

0.714

0.838

0.88

WBC (× 10ꝰ /L)

14.06 ± 3.78

14.25 ± 4.66

14.13 ± 4.14

0.968

0.933

0.902

CRP (mg/L)

153.94 ± 115.24

210.73 ± 111.22

194.64 ± 114.55

0.024^*

0.06

0.506

BUN (mmol/L)

5.40 ± 5.39

7.39 ± 15.47

4.75 ± 2.00

0.438

0.519

0.831

Serum creatinine (μmol/L)

66.98 ± 18.05

71.73 ± 35.03

71.27 ± 26.54

0.94

0.534

0.604

Ca²⁺ (mmol/L)

2.05 ± 0.25

2.05 ± 0.24

2.07 ± 0.22

0.828

0.968

0.939

GLU (mmol/L)

9.29 ± 4.49

11.48 ± 4.87

11.20 ± 5.82

0.021^*

0.057

0.518

TG (mmol/L)

15.33 ± 15.80

17.80 ± 19.20

20.55 ± 22.26

0.861

0.409

0.602

TC (mmol/L)

8.57 ± 4.92

9.17 ± 5.21

9.76 ± 5.63

0.542

0.239

0.673

Diabetes mellitus, n (%)

18, 35%

30, 60%

39, 64%

0.01^*

0.002^**

0.671

Hypertension, n (%)

13, 25%

11, 22%

12, 20%

0.721

0.496

0.763

Fatty liver, n (%)

43, 83%

45, 90%

50, 82%

0.284

0.92

0.231

ARDS, number, n (%)

2, 4%

6, 12%

2, 3%

0.156

1.000

0.137

SAP number, n (%)

2, 4%

6, 12%

2, 3%

0.156

1.000

0.137

MSAP & SAP number, n (%)

29, 56%

26, 52%

28, 46%

0.703

0.296

0.522

CTSI > 4 score number, n (%)

18, 35%

26, 52%

28, 46%

0.076

0.224

0.522

Recurrence, n (%)

32, 62%

26, 52%

30, 49%

0.331

0.188

0.768

Repeated recurrence, n (%)

24, 46%

13, 26%

23, 38%

0.034^*

0.364

0.19